Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Forbes contributors publish independent expert analyses and insights. Non-fungible tokens have transformed the art world, offering artists innovative ways to create, sell and profit from their digital ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

We have a whole house Generac generator installed in 2017 or 18 with a 10 year warranty. We thought we were covered for power outages. It seems that every year, for the last 3 -4 years something goes ...

Consider dividend yield over size; focus on business quality and ability to maintain payouts. Invest in stocks like Lowe's for long-term gains as they increase dividends regularly. Diversify by adding ...